PillTablet
Armodafinil
Armodafinil
2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US8 NDCs
2 active makers
2 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)—
US makers2 labelers
Packages9
DEA / ScheduleCIV
US acquisition costNADAC · per unit
Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$34.752
Latest avg · Jan 21, 2026
+0%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
31
Rx · 2025 Q4
926
Units dispensed
4
Quarters · since 2025 Q1
Who makes it2 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Cephalon, LLC | unknown | 5 | SUPPLYING |
| Patheon Inc. | unknown | 4 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.